Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Chemotherapy Induced Peripheral Neuropathy|Paclitaxel Induced Neuropathy
Interventions: DIAGNOSTIC_TEST: Quantitative measures of reduction in Chemotherapy Induced Neuropathy (CIPN) and Cognitive Impairment (CICI) in patients with stage I-III breast cancer
Sponsor: Yale University